Trial no.:
|
PACTR202107535738159 |
Date of Approval:
|
30/07/2021 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
A Comparative Study between Erector Spinae Plane Block with General Anesthesia versus Conventional Intravenous Analgesics with General Anesthesia in Patients undergoing Conserving Surgery for Breast Cancer |
Official scientific title |
A Comparative Study between Erector Spinae Plane Block with General Anesthesia versus Conventional Intravenous Analgesics with General Anesthesia in Patients undergoing Conserving Surgery for Breast Cancer |
Brief summary describing the background
and objectives of the trial
|
Acute postoperative pain is common after breast surgery, and despite conventional pain management, a large number of patients respond poorly to analgesics.Thoracic epidural, thoracic paravertebral block, pectoral block, and serratus plane block are commonly used techniques of regional anesthesia for breast surgery. All these techniques have their merits and demerits.
Erector spinae plane block (ESPB) is a newer technique of regional anesthesia to the chest wall, where local anesthetic is deposited between the transverse process and erector spinae muscle resulting in analgesia to the hemithorax.
Aim of this study is to assess the efficacy of ultrasound guided erector spinae plane block using 0.25% bupivacaine versus conventional multimodal intravenous analgesia on postoperative pain control after conserving surgery for breast cancer
The primary outcome measure of the study is amount of postoperative opioid consumption ,the secondary outcomes of the study are the visual analog scale (VAS), hemodynamic parameters, and rate of complications
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
pain management |
Anticipated trial start date |
15/04/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
15/04/2022 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
54 |
Actual target sample size (number of participants) |
|
Recruitment status |
Active, not recruiting |
Publication URL |
|
|